MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility
Nathan A. Ellis, Dezheng Huo, Ozlem Yildiz, Lisa J. Worrillow, Mekhala Banerjee, Michelle M. Le Beau, Richard A. Larson, James M. Allan, Kenan Onel
Research output: Contribution to journal › Article › peer-review
86Scopus
citations
Fingerprint
Dive into the research topics of 'MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility'. Together they form a unique fingerprint.